Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (371-380 of 405) with videos related to

Pageof 41
Sort By:
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Journal of Virology|August 22, 2014
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivoRebecca S Rudicell, Young Do Kwon, Sung-Youl Ko, et al.
Plos One|November 18, 2017
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120Allan C deCamp, Morgane Rolland, Paul T Edlefsen, et al.
Cell Reports|August 10, 2023
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopesRajeshwer S Sankhala, Vincent Dussupt, Gina Donofrio, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Science (New York, N.Y.)|August 10, 2013
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccineRobert A Seder, Lee-Jah Chang, Mary E Enama, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 41

Showing results (371-380 of 405) with videos related to

Sort By:
Pageof 41
NPJ Vaccines|March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine primingAllan C deCamp, Martin M Corcoran, William J Fulp, et al.
Journal of Virology|August 22, 2014
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivoRebecca S Rudicell, Young Do Kwon, Sung-Youl Ko, et al.
Plos One|November 18, 2017
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120Allan C deCamp, Morgane Rolland, Paul T Edlefsen, et al.
Cell Reports|August 10, 2023
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopesRajeshwer S Sankhala, Vincent Dussupt, Gina Donofrio, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Science (New York, N.Y.)|August 10, 2013
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccineRobert A Seder, Lee-Jah Chang, Mary E Enama, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 41